Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Investigator Perspectives

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Partnerships

Articles

She joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio, before joining 

 You can reach her at mebert@mjhlifesciences.com.

A new study finds women with postpartum hemorrhage face significantly higher odds of cardiovascular disease and thromboembolism for up to 15 years after childbirth.

Postpartum hemorrhage linked to long-term heart and blood clot risks

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: breast cancer prevention, uUTI trial, and more

A new study reveals rising breast cancer rates among minority women aged 65 to 74 years, highlighting the need for targeted screening and intervention strategies.

Breast cancer incidence trends vary by age, race, and stage in older women

Women with attention-deficit hyperactivity disorder are over 3 times more likely to experience premenstrual dysphoric disorder, especially when co-occurring with anxiety or depression, according to new research.

ADHD linked to higher risk of premenstrual dysphoric disorder

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Facebook

LinkedIn

RSS Feed

Spotlight

A Psychedelic to Treat Postpartum Depression?

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

View

Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression 

Lan Coffman, MD, PhD, discusses results and clinical implications derived from the findings of the phase III MIRASOL trial.

Dr Coffman breaks down the findings from the phase III MIRASOL trial, and provides insight surrounding the treatment options and potential clinical implications surrounding ovarian cancer treatment.

Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression

Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression

EP: 1.Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression

Newsletter